Timetable: Annual reassessment
Timetable: Annual reassessment
Timetable: Annual reassessment
Opinion/decision on a Paediatric investigation plan (PIP): Copanlisib, decision type: , therapeutic area: , PIP number: P/0385/2022
Timetable: Marketing authorisation renewal application
Opinion/decision on a Paediatric investigation plan (PIP): Zeposia,Ozanimod (hydrochloride), decision type: , therapeutic area: , PIP number: P/0392/2022
Opinion/decision on a Paediatric investigation plan (PIP): Crysvita,Burosumab, decision type: , therapeutic area: , PIP number: P/0411/2022
Compilation of Union procedures on inspections and exchange of information
CTIS newsflash - 15 September 2023
Network Portfolio Roadmap 2023-2025
List of industry subject matter experts and list of planned calls for industry subject matter experts
Towards a permanent collaboration framework for EMA and Health Technology Assessment bodies